The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 17, 2011

Filed:

Sep. 06, 2005
Applicants:

Renata Castiglioni Pascon, Campinas, BR;

Ana Claudia Rasera Silva, Campinas, BR;

Inventors:
Assignee:

Alellyx S.A., Campinas, BR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12P 21/06 (2006.01); A01H 1/00 (2006.01); C12N 15/82 (2006.01);
U.S. Cl.
CPC ...
Abstract

Disclosed are nucleic acids from the Citrus Leprosis Virus (CiLV) genome, associated with Citrus Leprosis (CiL) disease. Cloned CiLV nucleic acids can be used as probes or primers in assays for detecting CiLV in biological samples, particularly leaves, roots and other tissues of plants, such as plants fromand. The nucleic acid molecules can be introduced in cloning vectors and cloning the recombinant nucleic acid molecules in cells, such as prokaryotes, and eukaryotes. The cloned CiLV nucleic acids are expressed in cells to provide immunogenic proteins which can be used to raise antibodies against CiLV, which can then be used to detect CiLV virus in biological samples. Also disclosed are SEQ ID Nos. 5 and 8, in whole or part, transgenic plants, such as monocots and dicots, containing CiLV nucleic acids, in any combination, so that expression increases resistance to CiL disease.


Find Patent Forward Citations

Loading…